Navigation Links
Increase Diagnostic Confidence and Laboratory Productivity With New Novocastra HD Antibodies for IHC
Date:8/14/2012

NEWCASTLE, England, August 14, 2012 /PRNewswire/ --

Leica Microsystems announces the introduction of the Novocastra™ HD antibody range, 80 clinically important immunohistochemistry antibody clones, spanning 10 anatomical pathologies.

Novocastra HD was developed to meet the needs of pathologists and histologists, in terms of menu, diagnostic confidence and workflow.  This new 'Highly Definitive' range was created following extensive global market research on customer preferences, combined with the results of a comprehensive competitive evaluation* of each antibody by NordiQC.  The Novocastra HD menu therefore represents antibodies with independently qualified performance, each available in a range of new sizes and formats aligned to laboratory workloads.  

"When it comes to patient diagnosis, we know that excellence in staining quality isn't an option - it's an essential requirement," says Arnd Kaldowski, President of Leica Biosystems. "We ensured the optimized performance of each and every product and have compared performance on BOND with other leading clones in the market on competitive IHC stainers. The new Novocastra HD range represents our new trusted standard in the selection of high performing antibodies."

The Novocastra HD range will be available for sale in the USA and EU from August 2012, commencing with the breast pathology menu. Leica Microsystems plans to release a further nine disease specific ranges in 2012 and 2013.

About Leica Microsystems

Leica Microsystems is a world leader in microscopes and scientific instruments. Founded as a family business in the nineteenth century, the company's history was marked by unparalleled innovation on its way to becoming a global enterprise.

Its historically close cooperation with the scientific community is the key to Leica Microsystems' tradition of innovation, which draws on users' ideas and creates solutions tailored to their requirements. At the global level, Leica Microsystems is organized in four divisions, all of which are among the leaders in their respective fields: the Life Science Division, Industry Division, Biosystems Division and Medical Division.

Leica Microsystems' Biosystems Division, also known as Leica Biosystems, offers histopathology laboratories the most extensive product range with appropriate products for each work step in histology and for a high level of productivity in the working processes of the entire laboratory.

The company is represented in over 100 countries with 12 manufacturing facilities in 7 countries, sales and service organizations in 19 countries and an international network of dealers. The company is headquartered in Wetzlar, Germany.

For more information contact:
Dean Hutchinson
Marketing Communications Manager
Leica Biosystems Ltd
Balliol Business Park West
Benton Lane
Newcastle upon Tyne
NE12 8EW
Telephone: +44-191-215-0567
Fax: +44-191-215-1152
Direct Line: +44-191-215-4205
Email: dean.hutchinson@leica-microsystems.com



'/>"/>
SOURCE Leica Biosystems Ltd
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Star Scientific, Inc. Files Second-Quarter Financial Report (Net Sales and Gross Profits Continue to Increase) and Updates Research and Marketing Activities
2. Endoscopy Devices Market to 2018 - Demand for Cost-Effective, Minimally Invasive Procedures and Reimbursement for New Indications to Increase Uptake
3. Pharmaceutical Supply Chain in Japan - Periodic Drug Price Revisions by National Health Insurance Increase Competition and Squeeze Profit Margins
4. AMILPAR - Revenues Grow 18% and EBITDA Increases 19% in 1H12
5. Vesta Inc. Opens Frankfurt Office to Increase Service to Their Growing Medical Device Contracting Business Overseas
6. Long-Term Use of Blood Pressure Medications that Promote Sun Sensitivity May Increase Risk of Lip Cancer in Non-Hispanic Whites
7. Volcano Corporation Reports 13 Percent Growth In Second Quarter Revenues; FFR Disposable Revenues Increase 38 Percent
8. Survey: Hospital Executives Nationwide Facing Operating Room Case Volume Increases, Seeking Greater Efficiency through Healthcare Information Technology (HIT)
9. Amgens Second Quarter 2012 Revenues Increased 13 Percent To $4.5 Billion And Adjusted Earnings Per Share (EPS) Increased 34 Percent To $1.83
10. Life Technologies and SATuRN Collaborate to Increase Access to HIV Testing in Africa
11. New Plastic Blood Culture Bottles Increase Lab Convenience While Maintaining High-Quality Standards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2017)... Israel and NEW YORK , Sept. 27, ... with mobile health and big data solutions, today announced that its MyDario ... Please check your local TV listings for when The Dr. Oz Show ... ... season this month. ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history ... The Brink” is the creation of published author, William Nowers. Captain Nowers and ... WWII veteran, he spent thirty years in the Navy. Following his career as ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
Breaking Medicine News(10 mins):